DiaCarta Reports Positive Clinical Trial Data for Its Blood Based Test To Triage FIT-Positive Patients Enrolled in CRC Screening Programs
UF Innovate | Sid Martin Biotech alum DiaCarta Inc. has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical test)-positive patients in colorectal cancer (CRC) screening.
DiaCarta Helps Communities Scale Up Their MPOX Testing Efforts With Its Simple, Reliable, and FDA-EUA-Approved MPOX Testing Kits
UF Innovate | Sid Martin Biotech alum DiaCarta Inc., an experienced in-vitro diagnostics (IVD) company that provided COVID-19 testing kits during the global pandemic, has expanded its focus to MPOX detection and the detection of other infectious diseases.
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
UF startup Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that it has... Read More
UF Graduate Student Start-Up Focuses on Creating Chemicals From Ocean Microbes
In Jules Verne’s 20,000 Leagues Under the Sea, Captain Nemo describes the sea as “everything,” the “vast reservoir of Nature.” A pair of UF Ph.D. students are diving into these vast depths. They are harnessing the power of marine microbes and unlocking their potential for sustainable chemical applications. Jessica Tittl Nielsen (CEO) and Monica Schul (Chief Science Officer) founded a biotechnology company, Cordelia Biosciences, to create sustainable chemicals from ocean microbes.
RTI Surgical Has a New Chief Commercial Officer
UF startup RTI Surgical has appointed Chad Croasdale as chief commercial officer for his more than 20 years of commercial and financial experience in the medtech industry.
Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix™
UF startup Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced the launch of its newest product, Avive+ Soft Tissue Matrix™.
Ascend Acquires Beacon Gene Therapy Manufacturing Site
Ascend Advanced Therapies, a gene therapy development partner, has purchased Beacon Therapeutics’ contract, manufacturing, and controls team—along with the company's site, previously owned by UF Innovate | Accelerate graduate AGTC, located in Alachua, FL—a town considered to be a “biotech hub” in the state. The acquisition introduces a good manufacturing practice (GMP) plant into the fold, along with process and analytical development capabilities.
First Case of Accelerated Healing of a Recalcitrant Diabetic Ulcer Using Purified Amniotic Fluid
Neobiosis LLC, a client of UF Innovate | Accelerate @Sid Martin Biotech, recently presented the first case of accelerated healing of a diabetic ulcer using purified amniotic fluid. This research poses the use of this fluid as a possible treatment method for diabetic foot ulcers, one of the most painful complications of diabetes, and a difficult one to treat.
Entrinsic Bioscience Announces Breakthrough Innovation for Next Generation Sports and Recreational Rehydration™ Beverages
Entrinsic Bioscience has published a ground-breaking clinical study demonstrating the potential for next-generation sports and rehydration beverages, powered by its new Ultra-Hydrating HeatDefense™ formula which promotes dual action rapid rehydration with new levels of heat protection during sports, physical exertion and high heat stress.
BioMérieux Receives CE Mark for Biomarker Assay for Mild TBI
BioMérieux, which signed an agreement in 2017 with Banyan Biomarkers to commercialize its TBI assay, has obtained the CE Mark for its assay to detect two biomarkers associated with mild traumatic brain injury (mTBI).
